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The commentary of Dr Lehrer is appreciated as he and
colleagues pioneered the study of defensins in the late
1980s. He, however, underestimates those of us that have
focused our research on cutaneous biology when he states,
‘‘the world will little note nor long remember what is said
here’’. Despite Dr Lehrer’s humble protestations, his com-
mentary on our report regarding the functions of cathelici-
dins is an important glimpse into aspects of this field that
deserve further illumination and correction.
Caveats
Dr Lehrer raises three caveats of our study that warrant re-
sponse. First, he questions the use of cellulose acetate for
sweat collection. Analysis of cathelicidin abundance after el-
ution from cellulose acetate purposefully and conservatively
underestimates the abundance of these cationic amphipathic
peptides. This point only strengthens the potential for cath-
elicidins to provide antifungal activity at the skin surface and
supports our hypothesis. Next, he addresses issues regard-
ing the philosophical approach and experimental design that
implies the presentation of data from blood-killing assays or
subcutaneous inoculation of Candida albicans is not inform-
ative. Our results show the antifungal function of cathelicidin
peptides found on human skin, and highlights the depend-
ence of this activity on ionic and fungal growth conditions.
Importantly, neither skin injection nor a blood-killing assay
showed that killing at these sites was dependent on the
presence of cathelicidin in mice. This contrasts with control
experiments shown in parallel that reproduced previous ob-
servations of the susceptibility of Group A Streptococcus to
cathelicidins in blood. Therefore, this experimental design is
important in that it contrasts the potential role of cathelicidins
in defense against Candida to their role in defense against an
invasive bacteria and common cause of cellulitis. Philosoph-
ically, it is important to distinguish the role of cathelicidins in
deep tissue infections by Group A Streptococcus, from that
by C. albicans, the fourth most common cause of nosocomial
bloodstream infections (CDC 2004).
Antimicrobial peptides in the skin
The brief overview of the field of antimicrobial peptides of-
fered by Dr Lehrer should be clarified for the reader not
expert in this field. As he correctly points out, LL-37 is but
one of many peptides with antimicrobial activity. To expand
on this point and more accurately portray the current state
of the art, LL-37 is only one of multiple possible peptides
generated from the human cathelicidin precursor hCAP18
(Murakami et al, 2004). Beyond this, and ranging far greater
than the limited list discussed by Dr Lehrer, many molecules
have been found to inhibit or kill a variety of microbes when
studied in select in vitro culture conditions. Many of these
are expressed in the skin or subject to recruitment to the
skin during inflammation. For a greater discussion of this
point, the reader is directed to several more complete re-
cent reviews on the subject (Zasloff, 2002; Schroder, 2004;
Zanetti, 2004; Zaiou et al, 2005).
Recognition that many peptides have the potential for
antimicrobial activity does not equate with the concept
proposed by Dr Lehrer that these molecules are redundant.
At this time, only the cathelicidins have been confirmed in
animal models to provide immune defense of the skin (Nizet
et al, 2001). In fact, many of the antimicrobial peptides (in-
cluding b-defensins and some cathelicidins) will lose their
apparent antibiotic activity in the presence of 150 mM NaCl
or serum. Such inactivation of their function in physiologic
ionic conditions has long brought into question their role as
antimicrobial peptides, and demonstrates the necessity of
testing this hypothesis in animal model systems. This is par-
ticularly important as many alternative functions have been
identified for some peptides, and these functions present
alternative explanations for their presence in skin. Foremost
among the ‘‘non-antimicrobial’’ functions proposed for mol-
ecules like defensins and cathelicidins are a variety of host
cell signaling properties (Yang et al, 2002). For example, the
original discovery of an antimicrobial peptide in mammalian
skin was made based on the ability to induce proteoglycan
synthesis in fibroblasts (Gallo et al, 1994).
As the concepts of antimicrobial peptides in cutaneous
biology have evolved over the past few years (Gallo and
Huttner, 1998), we have learned to be careful not to be
misled by conclusions drawn exclusively from limited and
optimized assays done only in vitro. These molecules, per-
haps better called ‘‘Alarmins’’ for their roles as both effect-
ers and inducers of the innate immune response (Yang and
Oppenheim, 2004), are likely not a long list of genes with
redundant activity but rather specialized gene products that
function together to maximize defense of the skin. Perhaps
it is time to revise old speculations regarding the function of
molecules such as the b-defensins and let the data dictate
the conclusions.
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